Delivery Order SPE2DB24D9238-SPE2DB25FDQUH
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on June 3, 2025. The delivery order, which carries an ultimate completion date of June 25, 2025, covers the supply of Stelara 90 mg/ml syringes for distribution to military healthcare facilities. This award was issued without a set-aside designation, allowing the vendor to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 29, 2025, valued at $16,154.36. The delivery order, which has an ultimate completion date of October 21, 2025, is for Stelara 90 mg/ml syringes. This award was issued without a set-aside designation, allowing the contractor to compete directly in the open federal marketplace. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32,499.90 on August 13, 2025, by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, which is scheduled for completion by September 4, 2025, represents a continuation of the company's substantial role as a critical supplier within the federal pharmaceutical supply chain. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $16,249.95 from the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, issued without set-aside designation, covers the supply of Stelara 90 mg/mL syringes to support military healthcare operations. This award represents a single task order executed under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, which is expected to be completed by September 3, 2025, covers the supply of Stelara 90 mg/ml syringes to support Department of Defense healthcare facilities. This award was issued without a set-aside designation, demonstrating the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on September 8, 2025. The delivery order, which has an ultimate completion date of September 29, 2025, is for Stelara 90 mg/ml syringes—a prescription biologic medication used to treat autoimmune and inflammatory conditions. This award was issued without a set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $48,749.85 by the Defense Logistics Agency (DLA) on July 31, 2025. The delivery order, with an ultimate completion date of August 21, 2025, covers the supply of Stelara 90 mg/ml syringes—a prescription biologic medication used primarily for treating inflammatory conditions. This award carries no set-aside designation,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $97,499.70 by the Defense Logistics Agency (DLA) on August 8, 2025. This firm fixed-price delivery order is for the supply of Stelara 90 mg/ml syringes, with an ultimate completion date of August 29, 2025. The contract utilizes no set-aside designation, demonstrating the company's competitive positioning in federal procurement markets. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on July 14, 2025. The delivery order calls for the supply of Stelara 90 mg/ml syringes, a biologic medication used to treat autoimmune conditions. This award was made without a set-aside designation, and the order is scheduled for ultimate completion by August 4, 2025, with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, which will be completed by September 3, 2025, covers the supply of Stelara 90 mg/mL syringes, a biologic medication used to treat autoimmune conditions. This award carries no set-aside designation and represents a direct transaction under...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDQUHDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,441.36 by the Defense Logistics Agency (DLA) on May 6, 2025. The delivery order, which expires May 28, 2025, covers the supply of Stelara 90 mg/mL syringes to support federal healthcare operations. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open federal procurement marketplace. The company will perform at its facility in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's broader single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and extending through November 2026. This IDC establishes DMS Pharmaceutical Group as a critical supplier in the federal pharmaceutical supply chain, enabling the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. The company's established portfolio with the DLA demonstrates consistent capability in distributing branded and generic prescription drugs, biologics, and specialty medications to military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.4k | 5/6/25 |